HLB Pharmaceutical Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1998-04-01
- Employees
- 222
- Market Cap
- -
- Website
- http://www.hlbpharma.co.kr
C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration
Phase 4
Completed
- Conditions
- Spinocerebellar Degeneration
- Interventions
- Drug: C-Trelin OD Tab(5mg Taltirelin Hydrate)Drug: Placebo
- First Posted Date
- 2019-09-27
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- HLB Pharmaceutical Co., Ltd.
- Target Recruit Count
- 160
- Registration Number
- NCT04107740
- Locations
- 🇰🇷
Chonnam National University Hospital, Gwangju, Korea, Republic of
🇰🇷Gangnam Severance Hospital, Seoul, Korea, Republic of
🇰🇷The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul, Korea, Republic of
Phase 1 Single Dose Escalation Study of CTB-001
- First Posted Date
- 2012-07-24
- Last Posted Date
- 2012-07-24
- Lead Sponsor
- HLB Pharmaceutical Co., Ltd.
- Target Recruit Count
- 33
- Registration Number
- NCT01647893
- Locations
- 🇰🇷
Asan Medical Center, Seoul,, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath